What serotypes are in Pneumovax?
PNEUMOVAX® 23 is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, Page 3 2 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F).
How many serotypes are in a pneumococcal vaccine?
Pneumococcal conjugate vaccine (PCV13 or Prevnar13®) includes purified capsular polysaccharide of 13 serotypes of Streptococcus pneumoniae (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 19A, 19F, 18C, and 23F) conjugated to a nontoxic variant of diphtheria toxin known as CRM197.
How many serotypes of Streptococcus pneumoniae are there?
Objectives. There are currently 94 known pneumococcal capsular polysaccharide serotypes and their prevalence differs by geographic region and the period studied.
What is the difference between the two types of pneumonia vaccines?
The main difference between Pneumovax 23 and Prevnar 13 is how many different types of bacteria they target. Pneumovax 23 protects against 23 types of pneumococcal bacteria and is used in adults, while Prevnar 13 protects against 13 types of pneumococcal bacteria, and was designed primarily for children.
What is Pneumovax II?
Pneumovax II pneumococcal polysaccharide vaccine is recommended for immunisation against disease caused by pneumococcal serotypes contained in the vaccine. Pneumovax II is not effective for prevention of acute otitis media, sinusitis, or other common infections of the upper respiratory tract.
Should you get Prevnar or Pneumovax first?
For immunocompetent adult patients aged ≥65 years with CSF leak or cochlear implant, the CDC recommends a routine dose of Prevnar 13 (if not previously received) followed at least 8 weeks later by a routine dose of PNEUMOVAX 23.
What is a pneumococcal serotype?
Related Pages. Streptococcus pneumoniae are lancet-shaped, Gram-positive bacteria. There are 100 distinct serotypes of Streptococcus pneumoniae. The pneumococcal capsule serves as the target for current highly effective multivalent vaccines against this global pathogen.